Thysen SM, Fisker AB, INDEPTH working group on Vaccines and Child Survival. Selecting the right indicators to ensure optimised implementation of BCG vaccination policy. Vaccine 2018 (accepted).
At the latest Strategic Advisory Group of Experts (SAGE) on Immunization meeting, the working group discussed an extensive review of the evidence of BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacteria infections. We fear that these policy recommendations will not translate into the warranted changes in implementation unless they are accompanied by appropriate indicators. In this commentary, we suggest that BCG coverage should be reported as both coverage at 1 month and 12 months.
The work of the authors was supported by European Union FP7 support for OPTIMUNISE [Health-F3-2011-261375], DANIDA [grant no. 104.Dan.8-920]. The Research Centre for Vitamins and Vaccines, Bandim Health Project received support from the Danish National Research Foundation [DNRF108]. The funders had no role in the content or writing of the paper.